Core Points - Prismo Metals Inc. has successfully upsized and closed its non-brokered private placement, increasing the number of units from 12,500,000 to 17,450,000, resulting in gross proceeds of $1,745,000 due to strong investor demand [1][2] - The terms of the warrants associated with the units have been amended, with each unit now consisting of one common share and one full warrant, without the previous acceleration clause [2] - The net proceeds from the private placement will primarily be used for drilling at the Silver King project and for general corporate purposes, with an additional $125,000 expected from further subscriptions [3] Financial Details - The company issued 919,960 finder's warrants and paid finder's commissions totaling $92,398, along with a cash fee of $15,000 to a financial advisor in connection with the private placement [4] - All securities issued are subject to a four-month hold period under Canadian securities laws, and 303,275 units were issued to related parties, qualifying as a related party transaction [5] Company Overview - Prismo Metals Inc. is focused on mining exploration, particularly on three silver projects (Palos Verdes, Silver King, and Ripsey) and a copper project (Hot Breccia) located in Arizona [6]

Core Points - Integrated Cyber Solutions Inc. has successfully closed a non-brokered private placement financing, raising gross proceeds of C$3,025,000 by issuing 12,100,000 common shares at a price of C$0.25 per share, with the offering being over-subscribed by C$525,000 [1][2] - The net proceeds from the offering will be utilized for general working capital and software development [3] Company Overview - Integrated Cyber Solutions is an AI-powered cybersecurity company focused on protecting the human layer and advancing novel technologies to redefine enterprise security [5] - The company is developing a portfolio of intellectual property, including quantum-resilient AI deployment and data securitization architecture, aimed at safeguarding sensitive enterprise data and machine learning models against current and emerging threats [5] - The platform strategy of the company integrates secure AI deployment, behavioral intelligence, managed detection and response (MDR), and automated response into a scalable security operations layer, creating a differentiated moat that drives customer adoption and long-term shareholder value [6]

Core Points - Credissential Inc. has been granted a Management Cease Trade Order (MCTO) due to delays in filing its audited annual financial statements for the fiscal year ended June 30, 2025 [2][3] - The delay is attributed to the complexity of financial reporting, including the consolidation of two acquisitions and convertible note financings, which required additional audit procedures [4] - The company is working with its auditors to complete the audit and expects to file the Annual Filings by November 29, 2025 [5] Company Information - Credissential is a vertically integrated AI software development company focused on financial services [1][6] - The company intends to comply with alternative information guidelines by issuing biweekly default status reports until the Annual Filings are made [7] - There have been no material changes to the information disclosed in the default announcement from October 29, 2025 [7]

Core Points - Aequus Pharmaceuticals Inc. is providing additional information regarding its upcoming annual general and special meeting scheduled for November 21, 2025, at the request of the Ontario Securities Commission [1][2] - The company is clarifying details about a potential share consolidation, stating it will not proceed if certain conditions regarding market price changes or undisclosed material facts are met [3] - The company is also supplementing information related to cease trade orders affecting a director nominee, Marc Lustig, due to non-compliance with insider reporting requirements [5] Company Information - Aequus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on commercializing value-added products in specialty therapeutics areas within the Canadian market [6]

Core Viewpoint - Rockland Resources Ltd. has announced a non-brokered private placement to raise $180,000 through the issuance of 3 million units, aimed at advancing its Cole Gold Mines project and for general working capital [1][2]. Group 1: Financing Details - The private placement consists of 3 million units priced at $0.06 each, resulting in total gross proceeds of $180,000 [1]. - Each unit includes one common share and one transferable share purchase warrant, with warrants exercisable at $0.10 per share for 36 months [1]. - The financing proceeds will be allocated to the Cole Gold Mines project in Red Lake, Ontario, and for general working capital [1]. Group 2: Regulatory and Compliance Information - Shares issued from the financing will be subject to a four-month hold period in accordance with Canadian securities laws [2]. - Finders' fees will be applicable on the private placement, adhering to the policies of the Canadian Securities Exchange [2]. Group 3: Company Overview - Rockland Resources is focused on mineral exploration and discovery, with a portfolio that includes the historic Cole Gold Mines project and a beryllium exploration portfolio in Utah [3]. - The company aims to leverage geological expertise and strategic project development to deliver growth and long-term value to shareholders [3].

 November 12, 2025, Vancouver, British Columbia – TheNewswire - Happy Creek Minerals Ltd. (TSX-V: HPY) (“Happy Creek” or the “Company”) is pleased to announce that the Company has entered into the following marketing and promotion related contracts.MarketSmart Communications Inc. (“MarketSmart”) MarketSmart is a Vancouver, British Columbia-based corporate communications service provider, built over the last two decades, who benefit from a deep industry knowledge in venture capital and small cap investing. ...

Core Insights - Pinnacle Silver and Gold Corp. has reported significant sampling results from the historic La Dura mine at the El Potrero gold-silver project in Durango, Mexico, indicating an extension of the mineralized strike length along the Dos de Mayo vein structure to nearly 500 metres, with untested gaps between principal mines [1][3] Group 1: Sampling Results - The La Dura mine features a main adit extending approximately 60 metres along the vein, with two smaller adits collectively known as La Dura 2, which have shown consistent mineralization [2] - Channel sampling has revealed an average grade of 1.98 g/t Au and 98 g/t Ag over a 12 metre strike length, with individual grades reaching up to 4.51 g/t Au and 269 g/t Ag over 0.5 metres [2] - The mineralized zone is only partially exposed, suggesting significant potential for expansion through further mine development and drilling [2][3] Group 2: Exploration Potential - There is approximately 150 metres between La Dura and the Pinos Cuates mine, where previous sampling returned grades of up to 85 g/t Au and 520 g/t Ag over 0.5 metres, indicating further drill testing is warranted [3] - An additional 120 metres of untested strike potential exists between Pinos Cuates and the Dos de Mayo mine, along with over 1,000 metres to the northwest of La Dura, all of which are planned for drill-testing once surface permits are secured [3] Group 3: Geological Context - Surface and underground mapping is currently focused on a north-south trending vein called La Estrella, located approximately 500 metres southwest of the Dos de Mayo trend, which may indicate significant mineralization potential due to the intersection of structural trends [4] - The El Potrero project is situated in the Sierra Madre Occidental, an area known for high-grade gold-silver mineralization within a low sulphidation epithermal breccia vein system [11][12] Group 4: Project Development - The property has a previously operational 100 tpd plant that can be refurbished for near-term production, with the site being road accessible and within three kilometres of a power line [13] - Pinnacle aims to earn an initial 50% interest upon commencing production, with plans to generate cash flow for further project development and increase ownership to 100% subject to a 2% NSR [14] Group 5: Company Overview - Pinnacle Silver and Gold Corp. is focused on developing precious metals projects in the Americas, with a commitment to building long-term, sustainable value for shareholders [15]

Core Insights - Adamera Minerals Corp. is conducting a field program on its 100% owned South Hedley Gold-Copper Project in southern British Columbia, utilizing geochemistry and geophysics to enhance the Max and Glix prospects [1][3] - The South Hedley property spans 18,714 hectares and is located within a mineral-rich belt, which includes significant historical mines such as the Nickel Plate gold mine and the Copper Mountain mine [2] Exploration Highlights - At the Max Prospect, a strong gold-in-soil anomaly has been identified, with gold values exceeding 1.0 g/t in multiple samples, including a notable sample of 1,340 ppb (1.34 g/t) [4] - The Max Prospect is associated with quartz-rhodonite veining and alteration, and the anomaly is partially coincident with a deep magnetic feature [4] - At the Glix Prospect, assays have shown gold values ranging from 24 to 4,283 ppb (4.3 g/t), along with significant zinc and arsenic [6][9] - The November program will include extending the soil grid and conducting detailed ground magnetic and VLF-EM surveys to refine drill targets [8][9] Company Overview - Adamera Minerals Corp. is focused on exploring high-grade gold and base metal deposits in Canada and the USA, with projects that have near-term discovery and development potential [10]

Core Points - Angkor Resources Corp. has signed a service agreement with Departures Capital Inc. for a targeted digital marketing and investor outreach campaign [1][2] - The campaign aims to enhance Angkor's visibility in the global investment community through various digital initiatives [2] - The total contract value for the services is US$25,000, payable in advance [3] Company Overview - Angkor Resources Corp. is a public company listed on the TSX-Venture Exchange, focusing on mineral and energy solutions in Cambodia and Canada [3] - The company's Cambodian energy subsidiary, EnerCam Resources, holds an onshore oil and gas license covering over 4,095 square kilometers [4] - EnerCam is actively engaged in oil and gas exploration in Cambodia, aiming to establish the country as an oil and gas producer [4] Environmental Commitment - Angkor's Canadian subsidiary, EnerCam Exploration Ltd., is involved in oil and gas production in Saskatchewan and has initiated carbon and gas capture projects [5] - The carbon capture initiative is part of Angkor's long-term commitment to environmental and social projects, promoting cleaner energy solutions [5] Mineral Exploration - Angkor Gold Corp., the mineral subsidiary of Angkor, holds two mineral exploration licenses in Cambodia, focusing on copper and gold prospects [6]

Core Insights - Lexaria Bioscience Corp. has extended its Material Transfer Agreement (MTA) with PharmaCO until April 30, 2026, to allow for the review of data from an Australian study [2][3] - The MTA enables continued collaboration and strategic planning discussions between Lexaria and PharmaCO's clinical development team [2] - Lexaria's DehydraTECH™ technology aims to enhance drug delivery through oral administration, improving bio-absorption and reducing side effects [4] Summary by Sections Material Transfer Agreement Update - The MTA originally signed on September 4, 2024, has been extended to accommodate PharmaCO's review of Lexaria's Australian study data [2] - This extension allows both parties to maintain their relationship and keep the temporary exclusive license active [2] Pre-Clinical Studies and Future Expectations - Initial pre-clinical studies examining pharmacokinetics in animals have been completed [3] - Lexaria is awaiting PharmaCO's review of safety, pharmacokinetic, and efficacy data from its independent Australian human clinical study, with final results expected by the end of Q4 2025 [3] About Lexaria and DehydraTECH - DehydraTECH™ is a patented drug delivery platform that enhances the absorption of various drugs through oral delivery [4] - Lexaria holds a strong intellectual property portfolio with 54 patents granted and additional patents pending globally [4]